Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preliminary results reported for IL-2 gene therapy in GI cancer

Nov. 26, 1997

Positive phase I/II results reported for adenoviral p53 gene therapy

Nov. 26, 1997

DNA-intercalating agents reported by Mitsui Toatsu in patent literature

Nov. 25, 1997

Daiichi synthesizes paclitaxel derivatives

Nov. 25, 1997

Axiom, Zaiya and Nippon Kagaku anticancer drug discovery alliance

Nov. 25, 1997

Techniclone reacquires rights to Oncolym

Nov. 25, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

Imutec licenses novel anticancer compounds from Ion

Nov. 21, 1997

New antitumor compound QM16-A described in patent literature

Nov. 21, 1997

HMR and MediGene collaborate on cancer gene therapies

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...